Inventor · disambiguated record
Claude Singer
Also filed as: SINGER CLAUDE
36 granted patents·39 pending applications·364 citations·filing 1993–2009
97Inventor score
Files withTEVA PHARMA32KOVACS LASZLO Z3SINGER CLAUDE3TEVA GYOGYSZERGYAR ZARTKOERUEE3BIOGAL GYOGYSZERGYAR2
Top patents by PatentIndex Score
75 records- 0192US6452054B2Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using themTEVA PHARMA·Filed 2000·Granted Sep 17, 2002·36 cites·74 claims
- 0292US6255526B1Preparation of gabapentinTEVA PHARMA·Filed 1997·Granted Jul 3, 2001·58 cites·19 claims
- 0386US6849120B2Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline formsTEVA PHARMA·Filed 2001·Granted Feb 1, 2005·24 cites·17 claims
- 0486US6764997B2Stabilized azithromycin compositionsTEVA PHARMA·Filed 2002·Granted Jul 20, 2004·29 cites·59 claims
- 0586US6365574B2Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereofTEVA PHARMA·Filed 1999·Granted Apr 2, 2002·59 cites·15 claims
- 0685US7060837B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2005·Granted Jun 13, 2006·3 cites·16 claims
- 0785US6586576B2Preparation method of azithromycin hydratesTEVA PHARMA·Filed 2001·Granted Jul 1, 2003·21 cites·37 claims
- 0885US6531509B2Stable gabapentin containing more than 20 ppm of chlorine ionTEVA PHARMA·Filed 2001·Granted Mar 11, 2003·19 cites·7 claims
- 0984US6600073B1Methods for preparation of sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2000·Granted Jul 29, 2003·14 cites·29 claims
- 1084US6500987B1Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 1999·Granted Dec 31, 2002·38 cites·89 claims
- 1183US7390807B2Crystal forms of lamotrigine and processes for their preparationsTEVA PHARMA·Filed 2005·Granted Jun 24, 2008·3 cites·13 claims
- 1282US7589128B2Process for preparation of amorphous form of a drugTEVA GYOGYSZERGYAR ZARTKOERUEE·Filed 2005·Granted Sep 15, 2009·6 cites·33 claims
- 1382US7022859B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2005·Granted Apr 4, 2006·2 cites·15 claims
- 1481US7358093B2Aztreonam L-lysine and methods for the preparation and analysis thereofCORUS PHARMA INC·Filed 2007·Granted Apr 15, 2008·6 cites·2 claims
- 1576US6909004B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2003·Granted Jun 21, 2005·5 cites·1 claims
- 1676US6852858B2Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the processBIOGAL GYOGYSZERGYAR·Filed 2002·Granted Feb 8, 2005·11 cites·19 claims
- 1775US6861426B2Crystal forms of lamotrigine and processes for their preparationsTEVA PHARMA·Filed 2002·Granted Mar 1, 2005·7 cites·100 claims
- 1874US6858652B2Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using themTEVA PHARMA·Filed 2002·Granted Feb 22, 2005·5 cites·14 claims
- 1972US7462737B2Pregabalin free of isobutylglutaric acid and a process for preparation thereofTEVA PHARMA·Filed 2006·Granted Dec 9, 2008·2 cites·6 claims
- 2072US7022881B2Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2004·Granted Apr 4, 2006·3 cites·6 claims
- 2170US6545149B2Synthesis and crystallization of piperazine ring-containing compoundsTEVA PHARMA·Filed 2001·Granted Apr 8, 2003·3 cites·24 claims
- 2268US6576764B2Synthesis and crystallization of piperazine ring-containing compoundsTEVA PHARMA·Filed 2002·Granted Jun 10, 2003·2 cites·5 claims
- 2367US7262293B2Aztreonam L-lysine and methods for the preparation thereofCORUS PHARMA·Filed 2004·Granted Aug 28, 2007·5 cites·4 claims
- 2465US7488846B2Pregabalin free of lactam and a process for preparation thereofTEVA PHARMACEUICAL IND LTD·Filed 2006·Granted Feb 10, 2009·2 cites·27 claims
- 2565US2008176949A1Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2008·Application pending·0 cites
- 2663US2008139808A1Crystal forms of lamotrigine and processes for their preparationsTEVA PHARMA·Filed 2008·Application pending·0 cites
- 2760US2006241189A1Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2006·Application pending·0 cites
- 2859US7622588B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2005·Granted Nov 24, 2009·0 cites·3 claims
- 2959US2009137821A1Method of making dorzolamide hydrochlorideKOVACS LASZLO ZSOLT·Filed 2008·Application pending·0 cites
- 3058US7678938B2Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acidTEVA PHARMA·Filed 2007·Granted Mar 16, 2010·0 cites·45 claims
- 3158US7619112B2Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acidTEVA PHARMA·Filed 2007·Granted Nov 17, 2009·0 cites·4 claims
- 3258US2005106239A1Stabilized azithromycin compositionsFiled 2004·Application pending·0 cites
- 3357US2008004319A1Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazoleBRAUDE VIVIANA·Filed 2007·Application pending·0 cites
- 3457US2004192622A1Stabilized azithromycin compositionsFiled 2004·Application pending·0 cites
- 3557US2006122271A1Stable gabapentin having pH within a controlled rangeSINGER CLAUDE·Filed 2006·Application pending·0 cites
- 3656US7683177B2Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazoleTEVA PHARMA·Filed 2004·Granted Mar 23, 2010·0 cites·8 claims
- 3756US2008280977A1Process for preparation of mycophenolate mofetil and other esters of mycophenolic acidMOLNAR SANDOR·Filed 2008·Application pending·0 cites
- 3856US2008281111A1Process for preparation of mycophenolate mofetil and other esters of mycophenolic acidMOLNAR SANDOR·Filed 2008·Application pending·0 cites
- 3955US2004147607A1Stable gabapentin having pH within a controlled rangeSINGER CLAUDE·Filed 2004·Application pending·0 cites
- 4054US2003055112A1Sertraline hydrochloride polymorphsFiled 2002·Application pending·0 cites
- 4153US7348429B2Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the processTEVA GYOGYSZERGYAR ZARTKOERUEN·Filed 2004·Granted Mar 25, 2008·0 cites·2 claims
- 4252US2007043241A1Optical resolution of 3-carbamoylmethyl-5-methylhexanoic acidHEDVATI LILACH·Filed 2006·Application pending·0 cites
- 4352US2003055109A1Stable gabapentin having pH within a controlled rangeFiled 2002·Application pending·0 cites
- 4452US2006155132A1Method of making dorzolamide hydrochlorideKOVACS LASZLO Z·Filed 2006·Application pending·0 cites
- 4551US7678816B2Method of stabilizing lansoprazoleTEVA PHARMA·Filed 2004·Granted Mar 16, 2010·0 cites·8 claims
- 4650US7683080B2Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcoholTEVA PHARMA·Filed 2003·Granted Mar 23, 2010·0 cites·18 claims
- 4750US2004176591A1Novel synthesis and crystallization of peperazine ring-containing compoundsFiled 2004·Application pending·0 cites
- 4850US2003120068A1Novel synthesis and crystallization of piperazine ring-containing compoundsFiled 2003·Application pending·0 cites
- 4949US7452991B2Aztreonam β polymorph with very low residual solvent contentTEVA GYOGYSZERGYAR ZARTKOERUEE·Filed 2004·Granted Nov 18, 2008·0 cites·46 claims
- 5049US2002045662A1Stable gabapentin having pH within a controlled rangeFiled 2001·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Claude Singer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →